AscellaHealth Earns Number One Spot for Fastest Growing Private Company and Number Two Spot on Philadelphia Business Journal “Soaring 76” Overall List of Fastest-Growing Companies
AscellaHealth has ranked second on the Philadelphia Business Journal’s 2023 “Soaring 76” list of fastest-growing companies in Greater Philadelphia and first for fastest-growing private company, as measured by revenue over a three-year period from 2020 through 2022. This is the Company’s fourth time…
PointClickCare Continues to Support the LTPAC Market and Enable Value-Based Care With its Leading Cloud-Based Solutions
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, announced its presence at the AHCA/NCAL Convention & Expo: Delivering Solutions 23. The company will join the long-term…
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on September 29, 2023. Four individuals were hired by Adicet in September 2023.…
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan,…
CVS Health appoints Michael F. Mahoney to its Board of Directors
CVS Health® Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the “Board”) of CVS Health, effective November 1. “Mike’s focus…
Pfizer Broadens Portfolio of Respiratory Vaccines Recommended by CDC Advisory Committee with ABRYSVO™ for RSV
Pfizer Inc. (NYSE: PFE) shared today it has broadened its portfolio of respiratory vaccines recommended by the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) following a favorable vote for ABRYSVO™ [Respiratory Syncytial Virus…
Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today provided updates on two Phase 3 trials, LEAP-006 and LEAP-008, evaluating KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase…
Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-A39 trial (also known as EV-302), which was conducted in collaboration with Seagen and Astellas, evaluating KEYTRUDA, Merck’s…
USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024
The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world’s first…
Global Cardiac Holter Monitor Market Size, Trends & Forecast Report 2023-2030 Featuring General Electric, NIHON KOHDEN, Hill-Rom, OSI Systems, Boston Scientific, Koninklijke Philips, and Medtronic – ResearchAndMarkets.com
The “Cardiac Holter Monitor Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. Global Cardiac Holter Monitor Market is projected to reach US$ 713.5 Million in 2030, growing at a CAGR…
Vicarious Surgical Receives Continued Listing Standard Notice From NYSE
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20, 2023,…
Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference
Kestra Medical Technologies is launching the ASSURE Clinician Experience (ACE), a program that lets electrophysiology and cardiology professionals wear and simulate use of the ASSURE® Wearable Cardioverter Defibrillator (WCD) system at The Heart Rhythm Society #HRX2023 global health and technology conference, September 21-23,…